Table III.
Effects of specific comorbidities on Ventricular Capacitance V30 in multivariate analysis
| NL and HTN and HFPEF | HTN and HFPEF | HFPEF | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | SE | p value | Coefficient | SE | p value | Coefficient | SE | p value | |
| Age | −0.60 | 0.21 | 0.004 | −0.56 | 0.27 | 0.035 | - | - | 0.44 |
| Sex (female) | −11.6 | 4.3 | 0.007 | −14.9 | 5.7 | 0.017 | −21.0 | 8.8 | 0.021 |
| Comorbidities | |||||||||
| Anemia | - | - | 0.33 | - | - | 0.36 | - | - | 0.40 |
| Overweight | - | - | 0.57 | - | - | 0.33 | - | - | 0.78 |
| Diabetes | - | - | 0.22 | - | - | 0.13 | 18.4 | 9.1 | 0.049 |
| CKD | 13.0 | 6.9 | 0.059 | 14.4 | 3.5 | 0.063 | 24.7 | 10.2 | 0.019 |
| CHD | 8.6 | 4.5 | 0.057 | 11.9 | 5.4 | 0.03 | - | - | 0.29 |
| LVH | 7.6 | 4.3 | 0.08 | 9.1 | 5.4 | 0.09 | 28.8 | 8.8 | 0.002 |
NL-normal controls, HTN-hypertensive controls without heart failure, HFPEF-heart failure and a preserved ejection fraction, CKD-chronic kidney disease, CHD-coronary heart disease, LVH-left ventricular hypertrophy